Additional file 6: of Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma

  • Noah Berlow (Creator)
  • Rishi Rikhi (Contributor)
  • Mathew Geltzeiler (Creator)
  • Jinu Abraham (Contributor)
  • Matthew N. Svalina (Creator)
  • Lara E. Davis (Creator)
  • Erin Wise (Creator)
  • Maria Mancini (Creator)
  • Jonathan Noujaim (Creator)
  • Atiya Mansoor (Contributor)
  • Michael J. Quist (Creator)
  • Kevin L. Matlock (Creator)
  • Martin W. Goros (Creator)
  • Brian S. Hernandez (Creator)
  • Yee C. Doung (Creator)
  • Khin Thway (Contributor)
  • Tomohide Tsukahara (Contributor)
  • Jun Nishio (Creator)
  • Elaine T. Huang (Creator)
  • Susan Airhart (Creator)
  • Carol J. Bult (Creator)
  • Regina Gandour-Edwards (Creator)
  • Robert G. Maki (Creator)
  • Robin L. Jones (Creator)
  • Joel E Michalek (Creator)
  • Milan Milovancev (Creator)
  • Souparno Ghosh (Contributor)
  • Ranadip Pal (Contributor)
  • Charles Keller (Creator)
  • Elaine C. Huang Huang (Creator)
  • Robin L. Jones (Creator)

Dataset

Description

Figure S6. STRINGdb visualizations of protein-protein interaction networks implicated by PTIM models. The protein-protein interaction networks here are derived from targets selected to define drug sensitivity during PTIM modeling. Edges in the STRINGdb graph represent confidence of interactions based on data from multiple published sources. Edges with confidence >â 0.9 are represented on the graph. The asterisk indicates targets validated in vitro. (A) Network of the set of targets common to the models developed for the GSK Orphan Kinome screen and the PPTI screen. Enrichment p-value
Date made available2019
PublisherFigshare

Cite this